Stable antitumor drug

Details Stable antitumor drug Stable antitumor drug

2001-05-11

2003-04-15

Peselev, Elli (Department: 1623)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

C536S007100

Reexamination Certificate

active

06548485

ABSTRACT:

TECHNICAL FIELD
The invention relates to cancer treatment, specifically to an improved stable anticancer agent which is a derivative of apoptolidin.
BACKGROUND ART
A microbial product, apoptolidin, has been isolated from Nocardiopsis sp. which selectively sensitizes cancer cells to apoptosis. (Kim, J. W., et al.,
Antibiot
. (1997) 50:628-630; Hayakawa, Y., et al.,
J. Am. Chem. Soc.
(1998) 120:3524-3525.) While apoptolidin shows considerable potency in its ability to induce apoptosis selectively, it is unstable under alkaline conditions, and, unfortunately, under neutral, physiological conditions. The present invention provides a more stable derivative of apoptolidin which retains the selective apoptosis inducing activity of apoptolidin.
DISCLOSURE OF THE INVENTION
The invention is directed to a stabilized derivative of apoptolidin which lacks the oleandrose and olivomycose sugars. The derivative is stable under physiological conditions and a potent selective antitumor agent.
Thus, in one aspect, the invention is directed to a compound of the formula
and the pharmaceutically acceptable esters and/or ethers thereof.
In other aspects, the invention is directed to pharmaceutical or veterinary compositions of the compounds of formula 1 and to methods to treat tumors by administering the compound of formula 1 or a pharmaceutical composition thereof. “Treatment” includes both therapeutic and prophylactic effects. In still other aspects, the invention is directed to a method to synthesize the compound of formula 1 by conversion from apoptolidin and optional esterification and on conversion to either forms.


REFERENCES:
Hayakawa et al., J. Am. Chem. Soc. (1998) 120:3524-3525.
Kim et al., Antibiot. (1997) 50:628-630.

Affiliated with

Also associated with

Rating

Stable antitumor drug does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Stable antitumor drug, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stable antitumor drug will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3008540